Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia

References

• Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(4):655–674. doi:10.1016/J.HOC.2009.04.009
   PubMed Web of Science ®Google Scholar
• Dorantes-Acosta E, Pelayo R. Lineage switching in acute leukemias: a consequence of stem cell plasticity? Bone Marrow Res. 2012;2012:406796–406718. doi:10.1155/2012/406796
   PubMedGoogle Scholar
• Stass S, Mirro J, Melvin S, et al. Lineage switch in acute leukemia. Blood. 1984;64(3):701–706. doi:10.1182/blood.V64.3.701.701
   PubMed Web of Science ®Google Scholar
• Rossi JG, Bernasconi AR, Alonso CN, et al. Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am J Hematol. 2012;87(9):890–897. doi:10.1002/AJH.23266
   PubMed Web of Science ®Google Scholar
• Kurzer JH, Weinberg OK. To B- or not to B-: a review of lineage switched acute leukemia. Int J Lab Hematol. 2022;44 Suppl 1(S1):64–70. doi:10.1111/IJLH.13923
   PubMedGoogle Scholar
• Haddox CL, Mangaonkar AA, Chen D, et al. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis. Blood Cancer J. 2017;7(9):e607–e607. doi:10.1038/BCJ.2017.89
   PubMedGoogle Scholar
• Horgan C, Kartsios C, Nikolousis E, et al. First case of near haploid Philadelphia negative B-cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation. Leuk Res Rep. 2020;14:100213. doi:10.1016/J.LRR.2020.100213
   PubMedGoogle Scholar
• Takeda R, Yokoyama K, Fukuyama T, et al. Repeated lineage switches in an elderly case of refractory B-cell acute lymphoblastic leukemia with MLL gene amplification: a case report and literature review. Front Oncol. 2022;12:799982. doi:10.3389/FONC.2022.799982/BIBTEX
   PubMed Web of Science ®Google Scholar
• Lamble AJ, Myers RM, Taraseviciute A, et al. KMT2A ­rearrangements are associated with lineage switch following CD19 targeting CAR T-cell therapy. Blood. 2021;138(Supplement 1):256–256. doi:10.1182/blood-2021-153336
   Google Scholar
• Mironova D, de Kraa R, Shipman P, et al. Successful treatment of a child with acute monoblastic leukaemia who relapsed with T-cell acute lymphoblastic leukaemia: a rare lineage switch. J Paediatr Child Health. 2022;58(12):2312–2315. doi:10.1111/JPC.16163
   PubMed Web of Science ®Google Scholar
• Lounici A, Cony-Makhoul P, Dubus P, et al. Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia: report of an adult case and review of the literature. Am J Hematol. 2000;65(4):319–321. doi:10.1002/1096-8652(200012)65:4
   PubMed Web of Science ®Google Scholar
• Montecino-Rodriguez E, Dorshkind K. Identification of B/macrophage progenitors in adult bone marrow. Semin Immunol. 2002;14(6):371–376. doi:10.1016/S1044532302000714
   PubMed Web of Science ®Google Scholar
• Hou YH, Srour EF, Ramsey H, et al. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood. 2005;105(9):3488–3492. doi:10.1182/BLOOD-2004-07-2839
   PubMed Web of Science ®Google Scholar
• Gardner R, Wu D, Cherian S, et al. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy. Blood. 2016;127(20):2406–2410. doi:10.1182/BLOOD-2015-08-665547
   PubMed Web of Science ®Google Scholar
• Wei J, Wunderlich M, Fox C, et al. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Cancer Cell. 2008;13(6):483–495. doi:10.1016/j.ccr.2008.04.020
   PubMed Web of Science ®Google Scholar
• Fujisaki H, Hara J, Takai K, et al. Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice. Exp Hematol. 1999;27(5):826–833. doi:10.1016/S0301-472X(99)00008-9
   PubMed Web of Science ®Google Scholar
• Semchenkova A, Mikhailova E, Komkov A, et al. Lineage conversion in pediatric B-cell precursor acute leukemia under blinatumomab therapy. Int J Mol Sci. 2022;23(7):4019. doi:10.3390/IJMS23074019
   PubMed Web of Science ®Google Scholar
• Ruella M, Maus MV. Catch me if you can: leukemia escape after CD19-Directed T cell immunotherapies. Comput Struct Biotechnol J. 2016;14:357–362. doi:10.1016/J.CSBJ.2016.09.003
   PubMed Web of Science ®Google Scholar
• Ruiz-Delgado GJ, Nuñez-Cortez AK, Olivares-Gazca JC, et al. Lineage switch from acute lymphoblastic leukemia to myeloid leukemia. MedicinaUniversitaria. 2017;19(74):27–31. doi:10.1016/j.rmu.2017.02.001
   Google Scholar
• Choi S, Henderson MJ, Kwan E, et al. Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone. Blood. 2007;110(2):632–639. doi:10.1182/BLOOD-2007-01-067785
   PubMed Web of Science ®Google Scholar
• Wölfl M, Rasche M, Eyrich M, et al. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in MLL-rearranged infant ALL. Blood Adv. 2018;2(12):1382–1385. doi:10.1182/BLOODADVANCES.2018018093
   PubMed Web of Science ®Google Scholar
• Gagnon GA, Childs CC, LeMaistre A, et al. Molecular heterogeneity in acute leukemia lineage switch. Blood. 1989;74(6):2088–2095. doi:10.1182/blood.V74.6.2088.2088
   PubMed Web of Science ®Google Scholar
• Ihle R, Matthes H, Ihle H. Phenotype switch in acute leukemia patients after intensive chemotherapy. Haematol Blood Transfus. 1989;32:101–103. doi:10.1007/978-3-642-74621-5_16
   PubMedGoogle Scholar
• Shimizu H, Culbert S, Cork A, et al. A lineage switch in acute monocytic leukemia: a case report. Am J PediatrHematol Oncol. 1989;11(2):162–166. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=ovfta&NEWS=N&AN=00000370-198911020-00007.
   PubMed Web of Science ®Google Scholar
• Van Lierde S, Mecucci C, Van Daele MC, et al. Lineage switch and translocation t(9;ll) in acute leukemia. Am J Pediatr Hematol Oncol. 1989;11(1):20–22. doi:10.1097/00043426-198921000-00005
   PubMedGoogle Scholar
• Mura R, D'Angelo P, Rizzari C, et al. Lineage switch in a childhood T-cell acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1992;9(3):281–288. http://dx-1doi-1org-17ddmo68c00d4.han.gumed.edu.pl/103109/08880019209016598. doi:10.3109/08880019209016598
   PubMed Web of Science ®Google Scholar
• Cuneo A, Balboni M, Piva N, et al. CG. Lineage switch and multilineage involvement in two cases of pH chromosome-positive acute leukemia: evidence for a stem cell disease - PubMed. Haematologica. Published 1994. Accessed April 13, 2023. https://pubmed.ncbi.nlm.nih.gov/15378954/.
   Google Scholar
• Reardon DA, Hanson CA, Rofh MS, et al. Lineage Switch in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Cancer. 1994;73(5):1526–1532. doi:10.1002/1097-0142
   Google Scholar
• Shende AC, Zaslav AL, Redner A, et al. A de novo lineage switch from B-cell acute lymphoblastic leukemia to acute myelocytic leukemia: a case report. Am J Hematol. 1995;50(1):75–77. doi:10.1002/AJH.2830500131
   PubMed Web of Science ®Google Scholar
• Boeckx N, van der Velden VH, Boogaerts M, et al. An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia. Haematologica. 2004;89(8):e96–e98. https://haematologica-1org-1xj0a6o8c0101.han.gumed.edu.pl/haematologica/article/view/3203
   PubMedGoogle Scholar
• Germano G, Pigazzi M, del Giudice L, et al. Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia. Haematologica. 2006;91(5 Suppl):ECR09.
   PubMedGoogle Scholar
• Stasik C, Ganguly S, Cunningham MT, et al. Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia. Cancer Genet Cytogenet. 2006;168(2):146–149. doi:10.1016/J.CANCERGENCYTO.2006.02.013
   PubMedGoogle Scholar
• Chung HJ, Park CJ, Jang S, et al. A case of lineage switch from acute lymphoblastic leukemia to acute myeloid leukemia. Korean J Lab Med. 2007;27(2):102–105. doi:10.3343/KJLM.2007.27.2.102
   PubMedGoogle Scholar
• Mantadakis E, Danilatou V, Stiakaki E, et al. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia. Pediatr Blood Cancer. 2007;48(3):354–357. doi:10.1002/PBC.20543
   PubMed Web of Science ®Google Scholar
• Dorantes-Acosta E, Arreguin-Gonzalez F, Rodriguez-Osorio CA, et al. Acute myelogenous leukemia switch lineage upon relapse to acute lymphoblastic leukemia: a case report. Cases J. 2009;2(1):154. doi:10.1186/1757-1626-2-154/FIGURES/5
   PubMedGoogle Scholar
• Jiang JG, Roman E, Nandula SV, et al. Congenital MLL-positive B-cell acute lymphoblastic leukemia (B-ALL) switched lineage at relapse to acute myelocytic leukemia (AML) with persistent t(4;11) and t(1;6) translocations and JH gene rearrangement. Leuk Lymphoma. 2009;46(8):1223–1227. doi:10.1080/10428190500086055
   Google Scholar
• Sakaki H, Kanegane H, Nomura K, et al. Early lineage switch in an infant acute lymphoblastic leukemia. Int J Hematol. 2009;90(5):653–655. doi:10.1007/S12185-009-0446-7/TABLES/1
   PubMed Web of Science ®Google Scholar
• Shivarov V, Stoimenov A, Galabova I, et al. Very early onset of an acute myeloid leukemia in an adult patient with B-cell lymphoblastic leukemia. Int J Lab Hematol. 2009;31(1):106–113. doi:10.1111/J.1751-553X.2007.00968.X
   PubMed Web of Science ®Google Scholar
• Trikalinos NA, Soupir CP, Dey BR. Lineage switch of acute lymphocycticleukaemia with t(4;11)(q21;q23) into acute myeloid leukaemia in an adult patient after allogeneic stem cell transplantation. Br J Haematol. 2009;145(2):262–264. doi:10.1111/J.1365-2141.2009.07586.X
   PubMed Web of Science ®Google Scholar
• Imataki O, Ohnishi H, Yamaoka G, et al. Lineage switch from precursor B cell acute lymphoblastic leukemia to acute monocytic leukemia at relapse. Int J Clin Oncol. 2010;15(1):112–115. doi:10.1007/S10147-009-0007-3/METRICS
   PubMed Web of Science ®Google Scholar
• Park M, Koh KN, Kim BE, et al. Lineage switch at relapse of childhood acute leukemia: a report of four cases. J Korean Med Sci. 2011;26(6):829–831. cited April 12, 2023Available at: https://pubmed.ncbi.nlm.nih.gov/21655072/ doi:10.3346/jkms.2011.26.6.829
   PubMed Web of Science ®Google Scholar
• Park BG, Park CF, Jang S, et al. Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia. Korean J Lab Med. 2011;31(2):81–85. doi:10.3343/KJLM.2011.31.2.81
   PubMedGoogle Scholar
• Inoue A, Kawakami C, Takitani K, et al. Acute monoblastic leukemia that switched lineage at relapse to acute lymphoblastic leukemia: a case report. J Pediatr Hematol Oncol. 2012;34(6):e258–e260. doi:10.1097/MPH.0B013E318233219D
   PubMed Web of Science ®Google Scholar
• Grammatico S, Vitale A, La Starza R, et al. Lineage switch from pro-B acute lymphoid leukemia to acute myeloid leukemia in a case with t(12;17)(p13;q11)/TAF15-ZNF384 rearrangement. Leuk Lymphoma. 2013;54(8):1802–1805. doi:10.3109/10428194.2012.753450/SUPPL_FILE/DISCLOSURE.ZIP
   PubMed Web of Science ®Google Scholar
• Gupta SK, Kumar R, Chharchhodawala T, et al. Secondary pure erythroid leukaemia in relapsed acute lymphoblastic leukaemia: lineage switch or chemotherapy effect? BMJ Case Rep. May 19, 2014;2014:1–3. doi:10.1136/BCR-2013-201724
   Google Scholar
• Della Starza I, Ceglie G, Nunes V, et al. A case of lineage switch from B-cell acute lymphoblastic leukaemia to acute myeloid leukaemia. Role of subclonal/clonal gene mutations. Br J Haematol. 2016;174(4):648–651. doi:10.1111/BJH.13800
   PubMed Web of Science ®Google Scholar
• Rayes A, McMasters RL, O'Brien MM. Lineage switch in MLL-rearranged infant leukemia following CD19-directed therapy. Pediatr Blood Cancer. 2016;63(6):1113–1115. doi:10.1002/PBC.25953
   PubMed Web of Science ®Google Scholar
• Paganin M, Buldini B, Germano G, et al. A case of T-cell acute lymphoblastic leukemia relapsed as myeloid acute leukemia. Pediatr Blood Cancer. 2016;63(9):1660–1663. doi:10.1002/pbc.26054
   PubMed Web of Science ®Google Scholar
• Balducci E, Nivaggioni V, Boudjarane J, et al. Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy. Ann Hematol. 2017;96(9):1579–1581. doi:10.1007/S00277-017-3050-6
   PubMed Web of Science ®Google Scholar
• Nagel I, Bartels M, Duell J, et al. Hematopoietic stem cell involvement in BCR-ABL1–positive ALL as a potential mechanism of resistance to blinatumomab therapy. Blood. 2017;130(18):2027–2031. doi:10.1182/BLOOD-2017-05-782888
   PubMed Web of Science ®Google Scholar
• Zoghbi A, Zur Stadt U, Winkler B, et al. Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement. Pediatr Blood Cancer. 2017;64(11):e26594. doi:10.1002/PBC.26594
   Web of Science ®Google Scholar
• Wu B, Jug R, Luedke C, et al. Lineage switch between B-lymphoblastic leukemia and acute myeloid leukemia intermediated by “occult” myelodysplastic neoplasm: two cases of adult patients with evidence of genomic instability and clonal selection by chemotherapy. Am J Clin Pathol. 2017;148(2):136–147. doi:10.1093/AJCP/AQX055
   PubMed Web of Science ®Google Scholar
• Aldoss I, Song JY. Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab. Blood. 2018;131(22):2507–2507. doi:10.1182/BLOOD-2018-02-834911
   PubMed Web of Science ®Google Scholar
• Oberley MJ, Gaynon PS, Bhojwani D, et al. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65(9):e27265. doi:10.1002/PBC.27265
   PubMed Web of Science ®Google Scholar
• Aujla A, Hanmantgad M, Islam H, et al. Lineage switch from T-cell lymphoblastic leukemia/lymphoma to acute myeloid leukemia and back to T-cell lymphoblastic leukemia/lymphoma in a patient diagnosed during pregnancy. Stem Cell Investig. 2019;6:12–12. (May): doi:10.21037/SCI.2019.05.02
   PubMedGoogle Scholar
• Fournier E, Inchiappa L, Delattre C, et al. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature. Leuk Lymphoma. 2019;60(7):1827–1830. doi:10.1080/10428194.2018.1562185
   PubMed Web of Science ®Google Scholar
• He RR, Nayer Z, Hogan M, et al. Immunotherapy- (blinatumomab-) related lineage switch of KMT2A/AFF1 rearranged B-lymphoblastic leukemia into acute myeloid leukemia/myeloid sarcoma and subsequently into B/myeloid mixed phenotype acute leukemia. Case Rep Hematol. 2019;2019:7394619–7394614. doi:10.1155/2019/7394619
   PubMed Web of Science ®Google Scholar
• Lucero OM, Parker K, Funk T, et al. Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure. Br J Haematol. 2019;186(2):333–336. doi:10.1111/BJH.15812
   PubMed Web of Science ®Google Scholar
• Clesham K, Rao V, Bartram J, et al. Blinatumomab for infant acute lymphoblastic leukemia. Blood. 2020;135(17):1501–1504. doi:10.1182/BLOOD.2019004008
   PubMed Web of Science ®Google Scholar
• Li LZ, Sun Q, Fang Y, et al. A report on lineage switch at relapse of CD19 CAR-T therapy for philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia. Chin Med J. 2020;133(16):2001–2003. doi:10.1097/CM9.0000000000000962
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang L, Ren F, et al. A lineage switch from NPM1-mutant acute myeloid leukemia to acute T-cell lymphoblastic leukemia with KMT2D and ARID2 mutant. Int J Lab Hematol. 2021;43(4):O230–O233. doi:10.1111/ijlh.13534
   PubMed Web of Science ®Google Scholar
• Du J, Chisholm KM, Tsuchiya K, et al. Lineage switch in an infant B-lymphoblastic leukemia with t(1;11)(p32;q23); KMT2A/EPS15, following blinatumomab therapy. Pediatr Dev Pathol. 2021;24(4):378–382. doi:10.1177/10935266211001308
   PubMed Web of Science ®Google Scholar
• Park SJ, Han JH, Choi YW, et al. Lineage switch of B-lymphoblastic leukemia into acute myeloid leukemia with residual lymphoblasts in a patient with previous breast cancer. Int J Lab Hematol. 2021;43(4):O197–O199. doi:10.1111/IJLH.13510
   PubMed Web of Science ®Google Scholar
• Li T, Chen H, Zhang Y, et al. Very rare lineage switch from acute myeloid leukemia with BCR-ABL1 to B-lymphoblastic leukemia. Ann Hematol. 2021;100(6):1635–1636. doi:10.1007/S00277-021-04483-2
   PubMed Web of Science ®Google Scholar
• Lee BJ, Griffin SP, Doh J, et al. CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: a case report and literature review of increased lymphoid to myeloid lineage switch. Am J Hematol. 2022;97(12):E439–E443. doi:10.1002/AJH.26713
   PubMed Web of Science ®Google Scholar
• Li T, Chen M, Fu M, et al. Lineage switch from acute myeloid leukemia with KMT2A-PTD to mixed phenotype acute leukemia with t(v;11q23). Int J Lab Hematol. 2022;44(1):21–22. doi:10.1111/ijlh.13734
   PubMed Web of Science ®Google Scholar
• Pandit S, Wasekar N, Badarkhe G, et al. Acute lymphoblastic leukemia to acute myeloid leukemia: an unusual case report of lineage switching. Hematol Transfus Cell Ther. 2022;44(1):112–115. doi:10.1016/J.HTCT.2020.06.007
   PubMedGoogle Scholar
• Permikin Z, Popov A, Verzhbitskaya T, et al. Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: a case report. Leuk Res. 2022;112:106758. doi:10.1016/J.LEUKRES.2021.106758
   PubMed Web of Science ®Google Scholar
• Skhoun H, Khattab M, Chebihi ZT, et al. B/T mixed phenotype acute leukemia with high hyperdiploidy and lineage switch to B-cell acute leukemia. Leuk Res Rep. 2022;17:100289. doi:10.1016/J.LRR.2022.100289
   PubMedGoogle Scholar
• Zong L, Xie J, Kong J, et al. Lineage switch from acute myeloid leukemia to acute lymphoblastic leukemia. Leuk Lymphoma. 2022;63(9):2257–2259. doi:10.1080/10428194.2022.2064984
   PubMed Web of Science ®Google Scholar
• Jamil S, Sharma U, Singh C, et al. Lineage switch of acute myeloid leukemia to T-cell acute lymphoblastic leukemia - A unique case report. Indian J Pathol Microbiol. 2023;66(1):191–195. doi:10.4103/IJPM.IJPM_441_21
   PubMed Web of Science ®Google Scholar
• Ali S, Moreau A, Melchiorri D, et al. Blinatumomab for acute lymphoblastic leukemia: the first bispecific T‐cell engager antibody to be approved by the EMA for minimal residual disease. Oncologist. 2020;25(4):e709–e715. doi:10.1634/THEONCOLOGIST.2019-0559
   PubMed Web of Science ®Google Scholar
• Bill M, Mrózek K, Kohlschmidt J, et al. Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A. Proc Natl Acad Sci U S A. 2020;117(42):26340–26346. doi:10.1073/PNAS.2014732117/-/DCSUPPLEMENTAL
   PubMed Web of Science ®Google Scholar
• Chen C, Yu W, Alikarami F, et al. Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia. Blood. 2022;139(14):2198–2211. doi:10.1182/BLOOD.2021013442
   PubMed Web of Science ®Google Scholar
• Bataller A, Abuasab T, McCall D, et al. Myeloid lineage switch in KMT2A- rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica. 2024;109(1):293–297. doi:10.3324/HAEMATOL.2023.283705
   PubMed Web of Science ®Google Scholar
• Górecki M, Kozioł I, Kopystecka A, et al. Updates in KMT2A gene rearrangement in pediatric acute lymphoblastic leukemia. Biomedicines. 2023;11(3):821. doi:10.3390/BIOMEDICINES11030821
   PubMed Web of Science ®Google Scholar
• Winters AC, Bernt KM. MLL-Rearranged leukemias—an update on science and clinical approaches. Front Pediatr. 2017;5(1):4. doi:10.3389/FPED.2017.00004
   PubMedGoogle Scholar
• Tirtakusuma R, Szoltysek K, Milne P, et al. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia. Blood. 2022;140(17):1875–1890. doi:10.1182/BLOOD.2021015036
   PubMed Web of Science ®Google Scholar
• Iacobucci I, Mullighan CG. KMT2A-rearranged leukemia: the shapeshifter. Blood. 2022;140(17):1833–1835. doi:10.1182/BLOOD.2022017645
   PubMed Web of Science ®Google Scholar
• Issa GC, Ravandi F, DiNardo CD, et al. Therapeutic implications of menin inhibition in acute leukemias. Leukemia. 2021;35(9):2482–2495. doi:10.1038/S41375-021-01309-Y
   PubMed Web of Science ®Google Scholar
• Novakova M, Zaliova M, Fiser K, et al. DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica. 2021;106(8):2066–2075. doi:10.3324/HAEMATOL.2020.250423
   PubMed Web of Science ®Google Scholar
• van der Sluis IM, de Lorenzo P, Kotecha RS, et al. Blinatumomab added to chemotherapy in infant lymphoblastic leukemia. N Engl J Med. 2023;388(17):1572–1581. doi:10.1056/NEJMOA2214171
   PubMed Web of Science ®Google Scholar
• Tettamanti S, Pievani A, Biondi A, et al. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia. 2021;36(1):13–22. doi:10.1038/s41375-021-01350-x
   PubMed Web of Science ®Google Scholar
• Jiménez-Morales S, Aranda-Uribe IS, Pérez-Amado CJ, et al. Mechanisms of immunosuppressive tumor evasion: focus on acute lymphoblastic leukemia. Front Immunol. 2021;12:737340. doi:10.3389/FIMMU.2021.737340/BIBTEX
   PubMed Web of Science ®Google Scholar
• Taghiloo S, Asgarian-Omran H. Immune evasion mechanisms in acute myeloid leukemia: a focus on immune checkpoint pathways. Crit Rev Oncol Hematol. 2021;157:103164. doi:10.1016/J.CRITREVONC.2020.103164
   PubMed Web of Science ®Google Scholar